Coronavirus vaccine maker Moderna is giving away one of its mRNA-based treatments to a newly launched Stamford nonprofit — with the goal of developing a free treatment for people with an ultra-rare disease.
Moderna and the new Stamford-based Institute for Life Changing Medicines say they will collaborate on a new mRNA-based therapeutic for Crigler-Najjar Syndrome Type 1.